Update S3LL supportive therapy in oncological patients - where do we stand?

被引:0
|
作者
Jahn, F. [1 ]
机构
[1] Univ Klinikum Halle, Klin Innere Med 4, Hamatol Onkol, Halle, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS1
引用
收藏
页码:10 / 11
页数:2
相关论文
共 50 条
  • [41] Personalized therapy in pain management: where do we stand?
    Stamer, Ulrike M.
    Zheng, Lan
    Stueber, Frank
    PHARMACOGENOMICS, 2010, 11 (06) : 843 - 864
  • [42] Postmenopausal hormone replacement therapy: where do we stand?
    Emmerich, J.
    Alhenc-Gelas, M.
    Scarabin, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 78 - 78
  • [43] Combinatorial therapy in tumor microenvironment: Where do we stand?
    Kumari, Smita
    Advani, Dia
    Sharma, Sudhanshu
    Ambasta, Rashmi K.
    Kumar, Pravir
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [44] Antisense apolipoprotein B therapy: where do we stand?
    Akdim, Fatima
    Stroes, Erik S. G.
    Kastelein, John J. P.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) : 397 - 400
  • [45] Malaria therapy: where do we stand, what next?
    Grobusch, Martin Peter
    van Vugt, Michele
    FUTURE MICROBIOLOGY, 2010, 5 (10) : 1447 - 1449
  • [46] Gene Therapy for Heart Failure: Where Do We Stand?
    Naim, Charbel
    Yerevanian, Armen
    Hajjar, Roger J.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (02)
  • [47] Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
    Thanendrarajan, Sharmilan
    Davies, Faith E.
    Morgan, Gareth J.
    Schinke, Carolina
    Mathur, Pankaj
    Heuck, Christoph J.
    Zangari, Maurizio
    Epstein, Joshua
    Yaccoby, Shmuel
    Weinhold, Niels
    Barlogie, Bart
    van Rhee, Frits
    IMMUNOTHERAPY, 2016, 8 (03) : 367 - 384
  • [48] Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?
    Marios Adramerinas
    Dimitrios Andreadis
    Konstantinos Vahtsevanos
    Athanasios Poulopoulos
    Kalliopi Pazaitou-Panayiotou
    Hormones, 2021, 20 : 669 - 678
  • [49] Diabetes therapy and cancer risk: Where do we stand when treating patients?
    Sun, Grace E. Ching
    Kashyap, Sangeeta R.
    Nasr, Christian
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 81 (10) : 620 - 628
  • [50] Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?
    Adramerinas, Marios
    Andreadis, Dimitrios
    Vahtsevanos, Konstantinos
    Poulopoulos, Athanasios
    Pazaitou-Panayiotou, Kalliopi
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 20 (04): : 669 - 678